Price Alert

BiondVax Pharmaceuticals ... (BVXV)

NASDAQ: BVXV · Real-Time Price · USD

1.36

0.01 (0.74%)

At close: Sep 06, 2023, 9:59 PM

BiondVax Pharmaceuticals Balance Sheet Statement

Financials in ILS. Fiscal year is January - December.

Fiscal Year	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	7.51M	10.8M	14.07M	29.44M	39.5M	48.89M	54.04M	34.67M	39.88M	48.58M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	968K	969K	929K	444K	446K	437K	436K
Receivables	138K	119K	110K	713K	626K	619K	306K	1.43M	2.64M	481K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	7.77M	11.04M	14.37M	30.16M	40.13M	49.51M	55.05M	36.1M	42.52M	49.06M
Property-Plant & Equipment	12.13M	12.25M	12.7M	43.59M	44.48M	45.1M	44.11M	44.48M	45.09M	45.23M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	12.13M	12.25M	12.7M	44.56M	45.45M	46.03M	44.55M	44.93M	45.52M	45.67M
Total Assets	19.9M	23.29M	27.07M	74.72M	85.57M	95.54M	99.6M	81.03M	88.05M	94.72M
Account Payables	651K	1.31M	716K	1.05M	2.06M	4.1M	3.11M	3.31M	2.63M	2.08M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	394K	420K	382K	2M	19.56M	802K	773K	65.27M	65.01M	62.99M
Other Current Liabilities	843K	846K	1.24M	2.19M	1.9M	3.6M	3.33M	1.69M	1.74M	1.64M
Total Current Liabilities	1.89M	2.58M	2.34M	5.24M	23.52M	8.5M	7.21M	70.27M	69.39M	66.71M
Long-Term Debt	24.22M	22.86M	21.16M	60.02M	57.49M	70.77M	68.96M	5.91M	6.05M	5.98M
Other Long-Term Liabilities	902K	2.66M	5.33M	95K	95K	95K	95K	663K	1.23M	1.23M
Total Long-Term Liabilities	25.12M	25.52M	26.49M	60.11M	57.59M	70.87M	69.06M	6.57M	7.28M	7.21M
Total Liabilities	27.01M	28.1M	28.83M	65.36M	81.1M	79.37M	76.27M	76.84M	76.66M	73.92M
Total Debt	24.61M	23.28M	21.54M	62.02M	77.05M	71.57M	69.74M	71.17M	71.06M	68.97M
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-123.11M	-119.35M	-115.83M	-383.29M	-387.04M	-374.19M	-364.77M	-354.02M	-344.97M	-332.98M
Comprehensive Income	-1.74M	-1.89M	-2.01M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	-7.11M	-4.81M	-1.76M	9.36M	4.47M	16.17M	23.33M	4.19M	11.39M	20.8M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a